Biomerica Ratios and Metrics

Market cap in millions USD. Fiscal year is June - May.

Millions USD. Fiscal year is Jun - May.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 29, 2026	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022	May '21 May 31, 2021
Market Cap	7	8	10	23	45	45
Market Cap Growth	-17.09%	-20.42%	-57.66%	-48.83%	0.26%	-40.86%
Enterprise Value	6.24	5.47	6.05	14.11	40.16	42.01
Last Close Price	2.39	3.05	4.64	10.96	28.00	29.20
PEG Ratio	-	4.32	4.32	4.32	4.32	4.32
PS Ratio	1.71	1.46	1.80	4.32	2.39	6.24
PB Ratio	2.18	1.89	1.48	1.97	5.41	4.87
P/TBV Ratio	1.94	1.71	1.48	1.65	5.33	4.72
EV/Sales Ratio	1.44	1.03	1.12	2.64	2.13	5.84
Debt / Equity Ratio	-	0.02	0.07	0.07	0.12	0.14
Net Debt / Equity Ratio	-0.34	-0.47	-0.51	-0.74	-0.55	-0.28
Net Debt / EBITDA Ratio	0.23	0.41	0.56	1.26	1.15	0.36
Net Debt / FCF Ratio	0.36	0.51	0.63	1.56	8.47	0.48
Asset Turnover	0.79	0.70	0.46	0.41	1.63	0.50
Inventory Turnover	2.61	2.49	2.17	2.19	5.65	2.26
Quick Ratio	1.46	1.80	2.32	5.37	3.33	4.35
Current Ratio	2.64	2.80	3.51	6.58	4.69	7.10
Return on Equity (ROE)	-106.60%	-92.95%	-64.36%	-70.21%	-51.08%	-63.31%
Return on Assets (ROA)	-97.62%	-67.58%	-53.33%	-55.53%	-38.89%	-51.49%
Return on Invested Capital (ROIC)	-241.54%	-186.42%	-196.40%	-205.33%	-86.02%	-106.95%
Return on Capital Employed (ROCE)	-138.11%	-91.28%	-65.11%	-66.05%	-45.61%	-57.03%
Buyback Yield / Dilution	-18.46%	-9.22%	-18.87%	-11.69%	-6.24%	-17.34%
Total Shareholder Return	-18.46%	-9.22%	-18.87%	-11.69%	-6.24%	-17.34%

SEC Filings: 10-K · 10-Q